[HTML][HTML] Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
W Zhang, L Xu, HB Park, J Hwang, M Kwak… - Nature …, 2020 - nature.com
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
W Zhang, L Xu, HB Park, J Hwang, M Kwak… - Nature …, 2020 - ideas.repec.org
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
[HTML][HTML] Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
W Zhang, L Xu, HB Park, J Hwang, M Kwak… - Nature …, 2020 - ncbi.nlm.nih.gov
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
W Zhang, L Xu, HB Park, J Hwang… - Nature …, 2020 - ui.adsabs.harvard.edu
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy.
W Zhang, L Xu, HB Park, J Hwang, M Kwak… - Nature …, 2020 - europepmc.org
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
W Zhang, L Xu, HB Park, J Hwang… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy.
W Zhang, L Xu, HB Park, J Hwang… - Nature …, 2020 - search.ebscohost.com
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
W Zhang, L Xu, HB Park, J Hwang… - Nature …, 2020 - econpapers.repec.org
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy.
W Zhang, L Xu, HB Park, J Hwang, M Kwak… - Nature …, 2020 - europepmc.org
Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …
strategy used for cancer immunotherapy. In this study, we find that FimH, which is an …